| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/28/2010 | EP2210956A2 Method to inhibit cell growth using oligonucleotides |
| 07/28/2010 | EP2210947A2 Method for producing secreted proteins |
| 07/28/2010 | EP2210945A2 Neisseria meningitidis antigens |
| 07/28/2010 | EP2210904A1 Fusion protein comprising tumor necrosis factor related apoptosis inducing ligand and integrin ligand and use thereof |
| 07/28/2010 | EP2210900A2 Analogues of GLP-1 |
| 07/28/2010 | EP2210622A1 Therapeutic agent for heart disease, which is intended to be used in cell transplantation therapy |
| 07/28/2010 | EP2210617A1 Mammalian cells secreting Neurturin and their therapeutic use |
| 07/28/2010 | EP2210612A2 Macrocyclic antagonists of the motilin receptor |
| 07/28/2010 | EP2210611A1 Use of the sequence encoding the carboxyl-terminal domain of the heavy chain of tetanus toxin as a drug |
| 07/28/2010 | EP2210602A1 Compositions for the treatment of symptoms associated with respiratory inflammations |
| 07/28/2010 | EP2210598A2 Anticonvulsant amino acids for the treatment of pain |
| 07/28/2010 | EP2210589A1 Vesicular phospholipid gels comprising proteinaceous substances |
| 07/28/2010 | EP2210507A1 Bone-strengthening food material |
| 07/28/2010 | EP2210092A2 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof |
| 07/28/2010 | EP2209890A1 Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system |
| 07/28/2010 | EP2209801A2 Manufacture, compositions and uses of coagulationfactor viia modulator |
| 07/28/2010 | EP2209797A2 Modification of intrinsically disordered sequences for preparing vaccines |
| 07/28/2010 | EP2209528A1 Rapid acting injectable insulin compositions |
| 07/28/2010 | EP2209495A1 Taz/wwtr1 for diagnosis and treatment of cancer |
| 07/28/2010 | EP2209488A1 Fgf9-related methods for treating anxiety |
| 07/28/2010 | EP2209487A2 Human factor ix variants with an extended half life |
| 07/28/2010 | EP2209486A1 A method of treating cachexia with the removal or inactivation of macrophage inhibitory cytokine-1 |
| 07/28/2010 | EP2209458A1 Skin treatment compositions |
| 07/28/2010 | EP1713521B1 Haemostatic sprays and compositions |
| 07/28/2010 | EP1587921B1 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 07/28/2010 | EP1545560B1 Compositions for inhibiting protein kinase c alpha for the treatment of diabetes mellitus |
| 07/28/2010 | EP1459065B1 Processes for the measurement of the potency of glatiramer acetate |
| 07/28/2010 | EP1421199B1 Compositions for treating neurodegenerative diseases |
| 07/28/2010 | EP1397486B1 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 07/28/2010 | EP1250135B1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1871021B Treating or preventing restless legs syndrome using prodrugs of GABA analogs |
| 07/28/2010 | CN1764469B Papanicolau staining process |
| 07/28/2010 | CN1651457B Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
| 07/28/2010 | CN101790583A A method for detecting the binding between mdm2 and the proteasome |
| 07/28/2010 | CN101790539A Amelioration of cellular stress response |
| 07/28/2010 | CN101790538A Ucagon/glp-1 receptor co-agonists |
| 07/28/2010 | CN101790536A Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 07/28/2010 | CN101790369A Dosing methods for treating autoimmune diseases using a taci-ig fusion protein such as atacicept |
| 07/28/2010 | CN101787117A Preparation method and application of polyethylene glycol-polysialic acid block copolymers |
| 07/28/2010 | CN101787081A Thymosin alpha1-thymopoietin-2 fusion protein through genetic engineering |
| 07/28/2010 | CN101787078A Collagen polypeptide, preparation method and application thereof |
| 07/28/2010 | CN101787073A Methods and compositions for the treatment of gastrointestinal disorders |
| 07/28/2010 | CN101787072A Specific binding agents of human angiopoietin-2 |
| 07/28/2010 | CN101785856A Stably isoosmotic desmoteplase alpha1 or mutant preparation thereof |
| 07/28/2010 | CN101785855A Botulinum toxin formulations for oral administration |
| 07/28/2010 | CN101785854A Lutein multivitamin nutrition health care medicine composite and preparation method and applications thereof |
| 07/28/2010 | CN101785853A Mesenchymal stem cell biological winkle removing agent and preparation method thereof |
| 07/28/2010 | CN101785852A Dermis trace intervention anti-wrinkle cosmetic preparation and method |
| 07/28/2010 | CN101785782A Long-circulating ligustrazine composite injection and preparation method thereof |
| 07/28/2010 | CN101785765A Disposable hirudin stasis-eliminating hot compressing patch and applications thereof |
| 07/28/2010 | CN101229367B Process of preparing human fibrinogen preparation |
| 07/27/2010 | US7763719 Detecting tumor cells expressing TAG-72 using CC49 in which less than all six (three heavy chain and three light chain) Complementarity Determining Regions are present; host cells |
| 07/27/2010 | US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 07/27/2010 | US7763717 homogenizing skins, bones, scales, fins or biological organs with water, then solubilizing by adjusting the pH, adding antifoam agents and separating into light fraction containing lipids, a medium fraction containing proteins and a heavy fraction containing fat-free impurities |
| 07/27/2010 | US7763713 heterodimeric receptor complex comprising a receptor polypeptide and a interleukin-2 gamma receptor polypeptide, used for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; antibodies; immunology |
| 07/27/2010 | US7763712 Bone delivery conjugates and method of using same to target proteins to bone |
| 07/27/2010 | US7763709 purified immunoglobulin (IgE) binding immunogenic proteins, used in test kit for screening patients for allergies to food nuts |
| 07/27/2010 | US7763708 synthetic polypeptides capable of binding complement component C5a anaphylatoxin and inhibiting complement component C5a activity; antiinflammatory agents |
| 07/27/2010 | US7763707 synthetic proteins, used for the treatment and/or prevention of loss of body weight and body fat |
| 07/27/2010 | US7763706 cleaving proteins by enzymatic hydrolysis into peptides, then allowing the peptides to bind to a cation exchange resin, washing the cation exchange resin with an alkaline solution and eluting bound peptides from the resin with water; active compound in drugs, nutraceutical, beverages and food products |
| 07/27/2010 | US7763705 Viral peptides for use in activating immune response to treat and prevent viral infection |
| 07/27/2010 | US7763704 Chemically synthesized S3 peptide from Sushi3 domain of Factor C; endotoxin-sensitive serine protease binds, neutralizes lipopolysaccharide activity; Fluorescent tagged-S3 detects LPS-containing bacteria; pathogen-recognizing molecules, tandem multimers of the S3 gene constructed and expressed in E. coli |
| 07/27/2010 | US7763591 Hepatocyte growth factor gene as an active therapeutic agent; biodrugs; Parkinson's disease, Alzheimer's disease, spinal cord injury, diabetic peripheral neuritis, and ischemic cerebrovascular disorders (cerebral infarction, cerebral haemorrhage) |
| 07/27/2010 | US7763590 Nucleotide sequence complementary to wild-type gene; Rna strand which prevents gene expression |
| 07/27/2010 | US7763586 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/27/2010 | US7763584 Hepatitis C virus inhibitors |
| 07/27/2010 | US7763583 Endoparasiticidal compositions for topical application |
| 07/27/2010 | US7763582 Localized insulin delivery for bone healing |
| 07/27/2010 | US7763581 Mutants of trichosanthin with anti-tumor activity and lowered side-effects |
| 07/27/2010 | US7763580 In a tissue, organ or wound site using a synergistic mixture of transforming growth factor beta inhibitors and agents that degrade the excess accumulated extracellular matrix; fibrotic diseases and scarring |
| 07/27/2010 | US7763441 Modulators of gluconeogenesis |
| 07/27/2010 | US7763435 Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity |
| 07/27/2010 | US7763434 monoclonal antibodies against interleukin-15(IL-15) that prevent IL-15 from effecting signal transduction through the beta - or gamma -subunits of the IL-15 receptor complex; treating transplant rejection and graft-versus-host disease |
| 07/27/2010 | US7763283 Nitric oxide (NO) releasing material |
| 07/27/2010 | US7763281 hypotensive polypeptide in dairy product food; milk proteins as inhibitor of angiotensin I-converting enzyme; treating cardiovascular disease |
| 07/27/2010 | US7763270 uniformly coating the surface of a metal alloy carrier with a solution which has a dissolved bone morphogenic proteins to make a bone implants; for stimulate new bone formation |
| 07/27/2010 | US7763257 Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products |
| 07/27/2010 | US7763256 Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation |
| 07/27/2010 | US7763254 Human immunodeficiency virus integrase-LEDGF p75 isoform protein-protein interactions |
| 07/27/2010 | US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient. |
| 07/27/2010 | US7763242 Methods for treating myelodysplastic syndrome with a human interleukin-3-diphtheria toxin conjugate |
| 07/27/2010 | CA2462686C Fret protease assays for clostridial toxins |
| 07/27/2010 | CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/27/2010 | CA2436659C Cannabinoid receptor ligands |
| 07/27/2010 | CA2435425C A suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge |
| 07/27/2010 | CA2404000C A functional assay of high-density lipoprotein |
| 07/27/2010 | CA2339870C Antithrombin nucleotides and proteins from horn fly |
| 07/27/2010 | CA2332829C Vaccine delivery system |
| 07/27/2010 | CA2323091C Nephrin gene and protein |
| 07/27/2010 | CA2287872C Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/27/2010 | CA2236982C The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 07/27/2010 | CA2231801C Conjugates of a polypeptide and a biocompatible polymer |
| 07/27/2010 | CA2224080C Relaxin-like factor and methods and uses thereof |
| 07/27/2010 | CA2223300C Expression of lipoproteins |
| 07/22/2010 | WO2010083536A1 Protein conjugate having an endopeptidase-cleavable bioprotective moiety |
| 07/22/2010 | WO2010083504A2 Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections |
| 07/22/2010 | WO2010083495A2 Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha v beta 3 integrin |
| 07/22/2010 | WO2010083439A2 Recombinant human albumin-human granulocyte colony stimulating factor for the prevention of neutropenia |
| 07/22/2010 | WO2010083434A2 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor |